Uveitis, Intermediate clinical trials
The registry lists 31 studies for Uveitis, Intermediate across more than 10 countries. 3 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2026-07-13.
Status
- Completed
- 19
- Withdrawn
- 3
- Terminated
- 3
- Recruiting
- 2
- Status unknown
- 2
- Active, not recruiting
- 1
Phase
- Phase 3
- 11
- Phase 2
- 9
- Phase 4
- 6
- Phase 1
- 4
Where
- United States
- 23
- Germany
- 7
- India
- 6
- United Kingdom
- 6
- Canada
- 5
- Israel
- 4
Who runs them
Clearside Biomedical, Inc. (5) · Johns Hopkins University (2) · Lux Biosciences, Inc. (2) · EyePoint Pharmaceuticals, Inc. (2) · Ottawa Hospital Research Institute (1) · Quan Dong Nguyen (1) · Massachusetts Eye Research and Surgery Institution (1) · Mallinckrodt (1)
Studies
Recruiting first, then most recently updated. Showing 31 of 31 — search for more.
- Adalimumab Dose Adjustment for Pediatric Uveitis Treatment TrialNot yet recruitingNCT07699107Phase 43 countries
- The Use of Two YUTIQ Versus Sham for Treatment of Chronic Non Infectious Intraocular Inflammation Affecting the Posterior SegmentRecruitingNCT05486468Phase 31 country
- Ixekizumab for the Management of Refractory Non-Infectious Uveitis: A Proof-of-Concept StudyRecruitingNCT06085079Phase 41 country
- A Study of Brepocitinib in Adults With Active, Non-Infectious, Non-Anterior UveitisActive, not recruitingNCT06431373Phase 313 countries
- ACTH as A Re-emerging theRapy for Uveitis (The ACTHAR Study)CompletedNCT02931175Phase 21 country
- Ozurdex Monotherapy TrialWithdrawnNCT05101928Phase 41 country
- Safety and Efficacy of an Injectable Fluocinolone Acetonide Intravitreal (FAI) InsertTerminatedNCT05070728Phase 31 country
- Intravitreal Sirolimus as Therapeutic Approach to UveitisWithdrawnNCT01280669Phase 21 country
- Safety and Effectiveness of Acthar Gel for Inflammation of the Eye's Uvea (Middle Layer)TerminatedNCT03656692Phase 41 country
- Suprachoroidal Injection of CLS-TA in Patients With Non-infectious UveitisCompletedNCT03097315Phase 31 country
- MAGNOLIA: Extension Study of Patients With Non-infectious Uveitis Who Participated in CLS1001-301CompletedNCT029520012 countries
- Suprachoroidal Injection of CLS-TA in Subjects With Macular Edema Associated With Non-infectious UveitisCompletedNCT02595398Phase 33 countries
- Safety Study of Suprachoroidal Triamcinolone Acetonide Via Microneedle to Treat UveitisCompletedNCT01789320Phase 1/21 country
- Suprachoroidal Injection of Triamcinolone Acetonide in Subjects With Macular Edema Following Non-Infectious UveitisCompletedNCT02255032Phase 21 country
- Variations in Retinal Nerve Fiber Layer Thickness During Uncomplicated Anterior and Intermediate UveitisCompletedNCT028790841 country
- Safety,Tolerability and Efficacy of Intravitreal LFG316 in Patients With Active Non-infectious Intermediate-, posterior-or Panuveitis ,CompletedNCT01526889Phase 22 countries
- Safety and Efficacy Study of a FAI Insert in Subjects With Chronic Non-infectious Posterior UveitisCompletedNCT02746991Phase 31 country
- Pilot Project: The Amplicon and Metatranscriptomic Study of Intra and Extra Intestinal Microbiome in Non-infectious Uveitis DiseaseStatus unknownNCT041268501 country
- Study of the Effectiveness of Ozurdex for the Control of UveitisCompletedNCT02049476Phase 41 country
- Sirolimus as Therapeutic Approach to UveitisCompletedNCT00908466Phase 11 country
- Study of H.P. ACTHAR Subcutaneous Gelatin (Gel)(Highly Purified Gel Injection) in Uveitis PatientsCompletedNCT02764697Phase 41 country
- Safety &Efficacy of CF101 to Subjects With UveitisWithdrawnNCT01905124Phase 21 country
- Myfortic for the Treatment of Non-infectious Intermediate UveitisCompletedNCT01092533Phase 31 country
- Study of the Safety, Tolerability, and Bioactivity of Tocilizumab On Patients With Non-infectious UVEITIS: The STOP-UVEITIS StudyStatus unknownNCT01717170Phase 1/21 country
- Safety and Preliminary Efficacy Study of V404 PDS in UveitisTerminatedNCT02125266Phase 1/21 country
- Retisert and Cataract Surgery in Patients With Severe UveitisCompletedNCT00570830Not applicable1 country
- Randomized, Controlled Trial to Test the Efficacy of Interferon Beta in the Treatment of Intermediate UveitisCompletedNCT00344253Phase 31 country
- A Study of LX211 in Active Sight Threatening, Non-infectious Intermediate-, Anterior and Intermediate-, Posterior-, or Pan-UveitisCompletedNCT00404612Phase 37 countries
- A Study of LX211 in Clinically Quiescent Non-infectious Intermediate, Anterior and Intermediate, Posterior or Pan-UveitisCompletedNCT00404742Phase 37 countries
- Quality of Life in Patients With Intermediate UveitisCompletedNCT013144691 country
- A Study of the Safety and Efficacy of a New Treatment for Non-Infectious Intermediate or Posterior UveitisCompletedNCT00333814Phase 2/318 countries